Antonio Castrillo Selected Research

Obesity

1/2020	NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet.
1/2019	SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity.
4/2003	Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Castrillo Research Topics

Disease

15	Inflammation (Inflammations) 03/2024 - 02/2003
15	Atherosclerosis 04/2022 - 03/2003
7	Neoplasms (Cancer) 01/2023 - 11/2014
4	Infections 04/2022 - 06/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 10/2003
3	Obesity 01/2020 - 04/2003
2	Bacterial Infections (Bacterial Infection) 01/2017 - 02/2003
2	Metabolic Diseases (Metabolic Disease) 01/2016 - 11/2006
1	Peritonitis 03/2024
1	Rheumatoid Arthritis 03/2023
1	Fibrosarcoma 03/2023
1	Hypothyroidism 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Anemia 04/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Ventricular Dysfunction 10/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Pulmonary Alveolar Proteinosis 01/2018
1	Necrosis 02/2017
1	Autoimmune Diseases (Autoimmune Disease) 12/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2016
1	Glucose Intolerance 04/2016
1	Vascular Diseases (Vascular Disease) 06/2013
1	Dyslipidemias (Dyslipidemia) 06/2013
1	Hypertension (High Blood Pressure) 11/2012
1	Pre-Eclampsia (Preeclampsia) 11/2012
1	Ischemia 11/2012

Drug/Important Bio-Agent (IBA)

9	Liver X ReceptorsIBA 03/2024 - 02/2003
8	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2024 - 01/2004
8	LipidsIBA 01/2021 - 02/2003
6	CholesterolIBA 03/2024 - 10/2003
5	LigandsIBA 03/2024 - 02/2003
5	CytokinesIBA 02/2017 - 08/2005
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 12/2004
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2023 - 02/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2003
2	IronIBA 04/2022 - 01/2022
2	ElementsIBA 04/2022 - 02/2017
2	NucleotidesIBA 04/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Hormones (Hormone)IBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 10/2006
2	Interleukin-6 (Interleukin 6)IBA 02/2017 - 02/2003
2	Interleukin-10 (Interleukin 10)IBA 02/2017 - 06/2002
2	GW 3965IBA 09/2008 - 04/2003
2	oxidized low density lipoproteinIBA 02/2007 - 03/2005
1	EndotoxinsIBA 03/2024
1	Macrophage Colony-Stimulating FactorIBA 03/2023
1	MafB Transcription FactorIBA 03/2023
1	Testosterone (Sustanon)FDA Link 01/2023
1	PM 01183IBA 01/2023
1	TrabectedinIBA 01/2023
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2021
1	Caveolin 1IBA 01/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	ApolipoproteinsIBA 10/2020
1	c-Mer Tyrosine KinaseIBA 10/2020
1	InflammasomesIBA 10/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Thyroid HormonesIBA 01/2020
1	Succinic Acid (Succinate)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2018
1	phenalen-1-oneIBA 11/2018
1	Caspase 8 (Caspase-8)IBA 11/2018
1	Photosensitizing Agents (Photosensitizers)IBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018
1	Long Noncoding RNAIBA 01/2018
1	LDL Receptors (LDL Receptor)IBA 01/2018
1	SterolsIBA 01/2018
1	Protein Kinase InhibitorsIBA 02/2017
1	WEB 2086 (apafant)IBA 02/2017
1	Cyclic AMP (AMP, Cyclic)IBA 02/2017
1	Carrier Proteins (Binding Protein)IBA 02/2017
1	MitogensIBA 02/2017
1	Platelet Activating FactorIBA 02/2017
1	ZymosanIBA 02/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2017
1	NAD (NADH)IBA 01/2017
1	Multifunctional EnzymesIBA 01/2017
1	Insulin (Novolin)FDA Link 04/2016
1	Streptozocin (Streptozotocin)FDA Link 04/2016
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	Interleukin-1 (Interleukin 1)IBA 01/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2014
1	MicroRNAs (MicroRNA)IBA 06/2013
1	EndoglinIBA 11/2012
1	OxysterolsIBA 11/2012
1	Adenosine (Adenocard)FDA LinkGeneric 06/2011
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 06/2011

Therapy/Procedure

1	Radiotherapy 01/2019
1	Photochemotherapy (Photodynamic Therapy) 11/2018
1	Therapeutics 11/2014